Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Kureha discloses MMP-inhibitory esculetin derivatives

Aug. 16, 1996

Nisshin Flour Milling describes agents for septic shock

Aug. 16, 1996

P-selectin inhibitors reported by BMS

Aug. 16, 1996

MGI Pharma issued Israeli marketing approval for Salagen line extension

Aug. 9, 1996

Palauolol: A novel antiinflammatory phospholipase A2 inhibitor

Aug. 9, 1996

Niacinamide development update

Aug. 9, 1996

Japan Tobacco describes cell adhesion inhibitors

Aug. 9, 1996

Erythropoietin claimed as chronic inflammation treatment

July 26, 1996

World's first clinical trial on gene therapy for arthritis underway

July 26, 1996

Matrix metalloproteinase inhibitors described by British Biotech

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...